Preparation and Evaluation of 2-(Allylthio)Pyrazine-Loaded Lipid Emulsion with Enhanced Stability and Liver Targeting
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Jun-Hee | - |
dc.contributor.author | Kim, Chong-Kook | - |
dc.contributor.author | Choi, Han-Gon | - |
dc.contributor.author | Sung, Jung Hoon | - |
dc.date.accessioned | 2021-06-23T16:40:37Z | - |
dc.date.available | 2021-06-23T16:40:37Z | - |
dc.date.issued | 2009-03 | - |
dc.identifier.issn | 0363-9045 | - |
dc.identifier.issn | 1520-5762 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/41836 | - |
dc.description.abstract | To develop 2-(allylthio)pyrazine (2-AP)-loaded lipid emulsion for parenteral administration, various lipid emulsions were prepared with soybean oil, lecithin, and other carriers using homogenization method, and their physical stabilities were investigated by measuring their droplet sizes. The pharmacokinetics and tissue distribution of 2-AP in lipid emulsion after intravenous administration to rats were evaluated compared with 2-AP in solution. 2-AP was lipophilic, sparingly water-soluble, and unstable in aqueous medium. The 2-AP-loaded lipid emulsion composed of 1% of 2-AP, 4% of soybean oil, 4% of lecithin, and 91% of water was physically and chemically stable for at least 8 weeks. It gave significantly faster clearance of 2-AP and higher affinity to the organs, especially the liver, compared with the 2-AP in solution, suggesting that it could selectively deliver 2-AP to the liver. Thus, the lipid emulsion with soybean oil and lecithin could be used as a potential dosage form with the liver-targeting property and enhanced stability of sparingly water-soluble 2-AP. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.title | Preparation and Evaluation of 2-(Allylthio)Pyrazine-Loaded Lipid Emulsion with Enhanced Stability and Liver Targeting | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1080/03639040802363696 | - |
dc.identifier.scopusid | 2-s2.0-61649114706 | - |
dc.identifier.wosid | 000263560700011 | - |
dc.identifier.bibliographicCitation | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, v.35, no.3, pp 363 - 368 | - |
dc.citation.title | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | - |
dc.citation.volume | 35 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 363 | - |
dc.citation.endPage | 368 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | POTENTIAL CHEMOPROTECTIVE AGENT | - |
dc.subject.keywordPlus | DRUG-DELIVERY SYSTEMS | - |
dc.subject.keywordPlus | PARTICLE-SIZE | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordAuthor | 2-(allylthio)pyrazine | - |
dc.subject.keywordAuthor | lipid emulsion | - |
dc.subject.keywordAuthor | stability | - |
dc.subject.keywordAuthor | pharmacokinetics | - |
dc.subject.keywordAuthor | liver-targeting | - |
dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/03639040802363696 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.